Funding · Company
Cambrian BioPharma Inc
New York, NYBiotech & Pharma
Cambrian BioPharma Inc of New York, NY has disclosed $239M across 3 Form D offerings filed with the SEC between Dec 2, 2021 and Jul 15, 2026.
$239M
Total disclosed
3
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$124M
Form D · Jul 15, 2026 ↗
Q3 2026
· target $130M
$23M
Form D · Jan 13, 2025 ↗
Q1 2025
· 1 amendment, first filed Dec 22, 2023
· target $38M
$92M
Form D · Dec 2, 2021 ↗
Q4 2021
· target $101M
Filing details
HeadquartersNew York, NYIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001797409Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →